1 - 15 of 71 Results Clear All
The cutting-edge research methods that led to the discovery could be used to find other connections between environmental factors and birth defects.
News Release Research (Publication) Cardiovascular Disease Srivastava Lab
The award recognizes leaders who have made major contributions to the fields of cardiovascular and stroke science
Awards News Release Cardiovascular Disease Srivastava Lab
AHA with JAHA Podcast—In a roundtable forum, the American Heart Association’s 2023 Distinguished Scientists describe their contributions to stroke and cardiovascular research. Gladstone President Deepak Srivastava discusses the use of human iPS cells in drug discovery and his hopes for the future of science and medicine, including applications of artificial intelligence.
Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Human Genetics Stem Cells/iPSCs
How gene editing and stem cells are working in tandem at Gladstone Institutes to change science and medicine
Deep Dive Stem Cells/iPSCs CRISPR/Gene Editing Srivastava Lab Yamanaka Lab Doudna Lab Conklin Lab Marson Lab Huang Lab Ott Lab
CVS Health—Innovation in biomedical science is changing the way scientists think about the future of medicine. Gladstone President Deepak Srivastava describes how advances in genomics, gene editing, and cell programming may lead to new cures for human disease.
Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab CRISPR/Gene Editing Human Genetics
Gladstone scientists make headway toward new treatments for people with chronic long-term effects
Gladstone Experts Traumatic Brain Injury Neurological Disease Akassoglou Lab Paz Lab Srivastava Lab Deep Dive
Nob Hill Gazette—Home to 30 labs and 500 researchers, Gladstone is a hub of cutting-edge research and advances toward cures for the most devastating diseases.
Gladstone Experts Doudna Lab Greene Lab Ott Lab Srivastava Lab Weinberger Lab Yamanaka Lab Big Data CRISPR/Gene Editing Stem Cells/iPSCs
The APQC Blog—Gladstone President Deepak Srivastava, MD, President Emeritus Robert Mahley, MD, PhD, Senior Investigators Melanie Ott, MD, PhD, and Katie Pollard, PhD, explain how they and others at Gladstone create a collaborative research culture and plan to balance safety with the chance encounters that fuel creativity.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Huang Lab Ott Lab Pollard Lab Srivastava Lab Weinberger Lab
Gladstone researchers develop robust strategy for sifting through large-scale genetic data to better understand congenital heart problems
News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Krogan Lab Pollard Lab Srivastava Lab Stem Cells/iPSCs
ABC News—A new variant of SARS-CoV-2, dubbed Omicron, is causing concern around the world. Gladstone President Deepak Srivastava explains that some of the variant’s 50 mutations may have arisen when an individual who was already immunocompromised became infected with the virus. Senior Investigator Nevan Krogan describes how his group is investigating whether the new mutations will change the ability of the virus to enter cells and cause disease.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Srivastava Lab
ABC7 News—Gladstone President Deepak Srivastava, MD, and Senior Investigator Nevan Krogan, PhD, compare and contrast vaccines to Merck's new drug against COVID-19.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Krogan Lab Srivastava Lab
ABC7 News—A new study shows that wearing a mask increases slightly the amount of carbon dioxide children breathe. Gladstone President Deepak Srivastava, MD, cautions that the study was small, the increase in carbon dioxide is not known to be dangerous, and that wearing a mask and getting vaccinated remain the best protections against COVID-19.
COVID-19 Cardiovascular Disease Srivastava Lab
Gladstone researchers discover how to reverse cardiac scarring—and how this could treat heart failure
News Release Research (Publication) Heart Failure Cardiovascular Disease Alexanian Lab Srivastava Lab CRISPR/Gene Editing
abc News—Gladstone Institutes President Deepak Srivastava, MD, describes possible symptoms of blood clots after vaccination with the Johnson & Johnson vaccine, but reiterates that such side effects are extremely rare and should not be a reason for alarm for the millions of people who have already received their J&J shot.
COVID-19 Srivastava Lab
ABC7 News—Gladstone President Deepak Srivastava, MD, a pediatric cardiologist, explains how his group discovered a potential new drug to treat a debilitating disease due to the hardening of heart valves.
Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs
